The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
4 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $842,480 in first-year total cost, median $188,736.
Most frequent study sections
- Special Emphasis Panel[ZMD1 ML (07)]4
Most frequent institutions
- AGILE HEALTH, INC.1
- COG ANALYTICS, LLC1
- JYANT, INC.1
- NOVAZOI THERANOSTICS, INC.1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2015 | Anti-CXCL13 mAb to mitigate prostate cancer health disparities1R41MD010320-01 | SINGH, SHAILESH | JYANT, INC., GA | $315,320 | ZMD1 |
| 2015 | A novel racial disparity marker for risk prediction in triple negative breast cancer patients1R41MD010303-01 | ANEJA, RITU | NOVAZOI THERANOSTICS, INC., CA | $207,544 | ZMD1 |
| 2015 | Continuing Care App for Probationers and Parolees with Substance Use Disorders1R41MD008848-01A1 | GORDON, MICHAEL SCOTT | COG ANALYTICS, LLC, MD | $169,928 | ZMD1 |
| 2015 | Latinos Kick Buts: Mobile Engagement and Cessation Support for Latino Smokers1R41MD010318-01 | CUPERTINO, ANA PAULA | AGILE HEALTH, INC., TN | $149,688 | ZMD1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.